CA2147806A1 - Composes polyeniques, compositions pharmaceutiques et cosmetiques les contenant et utilisations - Google Patents

Composes polyeniques, compositions pharmaceutiques et cosmetiques les contenant et utilisations

Info

Publication number
CA2147806A1
CA2147806A1 CA2147806A CA2147806A CA2147806A1 CA 2147806 A1 CA2147806 A1 CA 2147806A1 CA 2147806 A CA2147806 A CA 2147806A CA 2147806 A CA2147806 A CA 2147806A CA 2147806 A1 CA2147806 A1 CA 2147806A1
Authority
CA
Canada
Prior art keywords
alkyl
lower alkyl
pharmaceutical
compositions containing
cosmetic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2147806A
Other languages
English (en)
Other versions
CA2147806C (fr
Inventor
Jean-Michel Bernardon
Philippe Nedoncelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Jean-Michel Bernardon
Philippe Nedoncelle
Centre International De Recherches Dermatologiques Galderma (Cird Galder Ma)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jean-Michel Bernardon, Philippe Nedoncelle, Centre International De Recherches Dermatologiques Galderma (Cird Galder Ma) filed Critical Jean-Michel Bernardon
Publication of CA2147806A1 publication Critical patent/CA2147806A1/fr
Application granted granted Critical
Publication of CA2147806C publication Critical patent/CA2147806C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/54—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/62—Unsaturated compounds containing ether groups, groups, groups, or groups containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Abstract

L'invention concerne de nouveaux composés polyéniques qui présentent comme formule générale (I):
CA002147806A 1994-04-26 1995-04-25 Composes polyeniques, compositions pharmaceutiques et cosmetiques les contenant et utilisations Expired - Fee Related CA2147806C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9405017A FR2719041B1 (fr) 1994-04-26 1994-04-26 Nouveaux composés polyéniques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR9405017 1994-04-26

Publications (2)

Publication Number Publication Date
CA2147806A1 true CA2147806A1 (fr) 1995-10-27
CA2147806C CA2147806C (fr) 2001-02-13

Family

ID=9462510

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002147806A Expired - Fee Related CA2147806C (fr) 1994-04-26 1995-04-25 Composes polyeniques, compositions pharmaceutiques et cosmetiques les contenant et utilisations

Country Status (21)

Country Link
US (2) US5705167A (fr)
EP (1) EP0679628B1 (fr)
JP (1) JP2653992B2 (fr)
KR (1) KR100191818B1 (fr)
AT (1) ATE165332T1 (fr)
AU (1) AU674269B2 (fr)
BR (1) BR9501614A (fr)
CA (1) CA2147806C (fr)
DE (1) DE69502130T2 (fr)
ES (1) ES2119325T3 (fr)
FI (1) FI951966A (fr)
FR (1) FR2719041B1 (fr)
GR (1) GR3026700T3 (fr)
HU (1) HU218612B (fr)
IL (1) IL113473A0 (fr)
MX (1) MX9501848A (fr)
NO (1) NO303493B1 (fr)
NZ (1) NZ270865A (fr)
PL (1) PL180746B1 (fr)
RU (1) RU2121995C1 (fr)
ZA (1) ZA952973B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US6083977A (en) * 1994-12-30 2000-07-04 Ligand Pharmaceuticals Incorporated Trienoic retinoid compounds and methods
CA2208981C (fr) * 1994-12-30 2008-08-26 Ligand Pharmaceuticals Incorporated Nouveaux composes de retinoide trienoique et methodes d'utilisation
US7115728B1 (en) * 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
EP0873295B1 (fr) 1995-10-06 2003-04-02 Ligand Pharmaceuticals, Inc. Modulateurs rxr selectifs pour les dimeres et leurs methodes d'utilisation
FR2755011B1 (fr) * 1996-10-31 1998-11-20 Cird Galderma Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles et/ou les dommages aigus induits par les rayonnements u.v.
US5998654A (en) * 1997-07-25 1999-12-07 Ligand Pharmaceuticals Incorporated Retinoic acid receptor antagonist compounds and methods
US7098025B1 (en) 1997-07-25 2006-08-29 Ligand Pharmaceuticals Incorporated Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor
KR20040031107A (ko) 1997-11-12 2004-04-09 에프. 호프만-라 로슈 아게 레티노이드 길항제를 이용한 제2형 ｔ-보조세포 중재면역질환의 치료
US6326397B1 (en) 1998-11-10 2001-12-04 Hoffman-La Roche Inc. Retinoid antagonists and use thereof
JP2002532458A (ja) 1998-12-17 2002-10-02 エフ．ホフマン−ラ ロシュ アーゲー アポプトシス誘発化合物としての７−アリル−６（ｚ）ヘプタトリエン酸レチナミド及び抗ガン剤としてのその使用
ES2221371T3 (es) * 1999-03-08 2004-12-16 Basilea Pharmaceutica Ag Antagonistas retinoides y el uso de los mismos.
JP2003508397A (ja) 1999-08-27 2003-03-04 リガンド・ファーマシューティカルズ・インコーポレイテッド アンドロゲンレセプターモジュレーターとしての８−置換−６−トリフルオロメチル−９−ピリド［３，２−ｇ］キノリン化合物
MXPA02002032A (es) 1999-08-27 2003-05-19 Ligand Pharm Inc Compuestos moduladores del receptor de androgeno y metodos.
US6566372B1 (en) 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
US6593493B1 (en) * 1999-09-14 2003-07-15 Ligand Pharmaceuticals, Inc. RXR modulators with improved pharmacologic profile
US7312247B2 (en) * 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) * 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
EP1511477A4 (fr) * 2002-05-22 2008-04-09 Errant Gene Therapeutics Llc Inhibiteurs d'histone desacetylase bases sur des composes alpha-ceto-epoxydes
CA2506504A1 (fr) * 2002-11-20 2004-06-03 Errant Gene Therapeutics, Llc Traitement de cellules pulmonaires avec des inhibiteurs d'histone deacetylase
CA2587013A1 (fr) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Inhibiteurs d'histone deacetylase
FR2910320B1 (fr) 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
FR2931661B1 (fr) 2008-05-30 2010-07-30 Galderma Res & Dev Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise et un retinoide.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3882157A (en) * 1972-07-27 1975-05-06 Zoecon Corp Thiolesters of phenylheptadienoic acids
US4201727A (en) * 1976-11-14 1980-05-06 Hoffmann-La Roche Inc. Fluorinated aromatic polyenes
LU77254A1 (fr) * 1977-05-04 1979-01-18
DE4036779A1 (de) * 1990-11-17 1992-05-21 Basf Ag Verwendung von arylpolyencarbonsaeuren und ihren derivaten als lichtschutzmittel in kosmetischen zubereitungen
CA2129773C (fr) * 1993-09-02 2007-05-01 Michael Klaus Derives d'acides carboxyliques aromatiques

Also Published As

Publication number Publication date
HU218612B (hu) 2000-10-28
AU674269B2 (en) 1996-12-12
USRE37947E1 (en) 2002-12-31
JPH08104653A (ja) 1996-04-23
JP2653992B2 (ja) 1997-09-17
FI951966A (fi) 1995-10-27
KR950029244A (ko) 1995-11-22
ATE165332T1 (de) 1998-05-15
RU95106674A (ru) 1996-12-27
NO951543D0 (no) 1995-04-24
EP0679628B1 (fr) 1998-04-22
KR100191818B1 (ko) 1999-06-15
MX9501848A (es) 1997-02-28
IL113473A0 (en) 1995-07-31
HU9501169D0 (en) 1995-06-28
NZ270865A (en) 1996-11-26
DE69502130D1 (de) 1998-05-28
FI951966A0 (fi) 1995-04-25
AU1651195A (en) 1995-11-16
GR3026700T3 (en) 1998-07-31
BR9501614A (pt) 1996-04-23
ES2119325T3 (es) 1998-10-01
DE69502130T2 (de) 1998-08-13
HUT74013A (en) 1996-10-28
RU2121995C1 (ru) 1998-11-20
PL180746B1 (pl) 2001-04-30
EP0679628A1 (fr) 1995-11-02
PL308342A1 (en) 1995-10-30
CA2147806C (fr) 2001-02-13
NO951543L (no) 1995-10-27
ZA952973B (en) 1995-12-19
FR2719041A1 (fr) 1995-10-27
US5705167A (en) 1998-01-06
FR2719041B1 (fr) 1996-05-31
NO303493B1 (no) 1998-07-20

Similar Documents

Publication Publication Date Title
CA2147806A1 (fr) Composes polyeniques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
CA2276278A1 (fr) Composes du type amine, et methode de production et utilisation connexes
ES8502105A1 (es) Un procedimiento para la preparacion de derivados de diben- zopirano
ES2091359T3 (es) Nuevo compuesto peptidico y un procedimiento para su preparacion.
CA2147807A1 (fr) Composes bicycliques-aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
BG103150A (en) Biaromatic compounds and pharmaceutical and cosmetic compositios containing them
AU3191293A (en) New naphthalene amides and sulphonamides, processes for their preparation and pharmaceutical compositions containing them
DE69720715D1 (en) Hexahydro-pyrido (4,3-b)indolderivate als antipsychotische arzneimittel
IL107068A0 (en) 5-oxo-dibenzo(a,d)cyclohepta-1,4-dienes,their preparation and pharmaceutical compositions containing them
ES8103030A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzamida.
TW252979B (fr)
DE3786865D1 (de) Aminosaeurederivate enthaltende antikonvulsive zusammensetzungen und verwendung dieser aminosaeurederivate.
CY2160B1 (en) Erburnane derivatives processes for their preparation and pharmaceutical compositions containing them
MY115430A (en) Glutaramide derivatives.
DE3773616D1 (en) Asymmetrische 1:2-chromkomplexfarbstoffe.
ES8406073A1 (es) Un procedimiento para la preparacion de nuevas benzamidas.
ES2027492A6 (es) Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables.
ES8705847A1 (es) Procedimiento para preparar nuevos derivados de n-(2-hidro- xialquil)-aminoacidos
GR3036243T3 (en) Ellipticine derivatives, their preparation and pharmaceutical compositions containing them
FI933652A (fi) Foerfarande foer framstaellning av 1-osubstituerade 3-aminopyrroler

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed